Placebo Use in the United Kingdom: Results from a National Survey of Primary Care Practitioners

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Howick, Jeremy ^a   Bishop, Felicity L ^b   Heneghan, Carl ^a   Wolstenholme, Jane ^c   Stevens, Sarah ^a   Hobbs, F D Richard ^a   Lewith, George ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; SODIUM CHLORIDE; SUGAR;

ARTICLE; CAREER; CLINICAL EFFECTIVENESS; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PILL; PLACEBO EFFECT; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; UNITED KINGDOM; VIRUS INFECTION;

CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MALE; PHYSICIANS, PRIMARY CARE; PLACEBOS; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 84875166030     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058247     Document Type: Article

References (54)

1. Berger JT, (1999) Placebo medication use in patient care: a survey of medical interns. The Western journal of medicine 170: 93-96.
2. Comaroff J, (1976) A bitter pill to swallow: placebo therapy in general practice. The Sociological review 24: 79-96.
3. de Craen AJ, Kaptchuk TJ, Tijssen JG, Kleijnen J, (1999) Placebos and placebo effects in medicine: historical overview. Journal of the Royal Society of Medicine 92: 511-515.
4. Fassler M, Gnadinger M, Rosemann T, Biller-Andorno N, (2009) Use of placebo interventions among Swiss primary care providers. BMC health services research 9: 144.
5. Fassler M, Meissner K, Schneider A, Linde K, (2010) Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies. BMC medicine 8: 15.
6. Goodwin JS, Goodwin JM, Vogel AV, (1979) Knowledge and use of placebos by house officers and nurses. Annals of internal medicine 91: 106-110.
7. Hrobjartsson A, Norup M, (2003) The use of placebo interventions in medical practice--a national questionnaire survey of Danish clinicians. Evaluation & the health professions 26: 153-165.
8. Kumar S, Little P, Britten N, (2003) Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ 326: 138.
9. Nitzan U, Lichtenberg P, (2004) Questionnaire survey on use of placebo. BMJ 329: 944-946.
10. Sherman R, Hickner J, (2008) Academic physicians use placebos in clinical practice and believe in the mind-body connection. Journal of general internal medicine 23: 7-10.
11. Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG, (2008) Prescribing 'placebo treatments': results of national survey of US internists and rheumatologists. BMJ 337: a1938.
12. Meissner K, Hofner L, Fassler M, Linde K, (2012) Widespread use of pure and impure placebo interventions by GPs in Germany. Family practice 29: 79-85.
13. Bostick NA, Sade R, Levine MA, Stewart DM Jr, (2008) Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs. J Clin Ethics 19: 58-61.
14. Foddy B, (2009) A duty to deceive: placebos in clinical practice. The American journal of bioethics: AJOB 9: 4-12.
15. WMA (2008) The Declaration of Helsinki. Ferney-Voltaire: WMA.
16. Howick J, (2009) Questioning the Methodologic Superiority of 'Placebo' Over 'Active' Controlled Trials American Journal of Bioethics. 9: 34-48.
17. Gotzsche PC, (1994) Is there logic in the placebo? Lancet 344: 925-926.
18. Grunbaum A, (1986) The placebo concept in medicine and psychiatry. Psychol Med 16: 19-38.
19. Nunn R, (2009) It's time to put the placebo out of its misery. BMJ 338: 1015.
20. Moerman DE (2002) Meaning, medicine, and the 'placebo effect'. Cambridge: Cambridge University Press.
21. Shapiro A, Morris LA (1978) The Placebo Effect in Medical and Psychological Therapies. In: Garfield SL, Bergin AE, editors. Handbook of Psychotherapy and Behavioural Change: An Empirical Analysis. New York: John Wiley & Sons. pp. 369-410.
22. Howick J (2008) Philosophical Issues in Evidence-Based Medicine: Evaluating the Epistemological Role of Double Blinding and Placebo Controls. London: London School of Economics.230 p.
23. Benedetti F, (2007) Placebo and endogenous mechanisms of analgesia. Handb Exp Pharmacol pp. 393-413.
24. Benedetti F, Amanzio M, Baldi S, Casadio C, Cavallo A, et al. (1998) The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression. Pain 75: 313-319.
25. Benedetti F, Amanzio M, Thoen W, (2011) Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology (Berl) 213: 791-797.
26. Benedetti F, Carlino E, Pollo A, (2011) How placebos change the patient's brain. Neuropsychopharmacology 36: 339-354.
27. Benedetti F, (2009) Placebo effects: understanding the mechanisms in health and disease. Oxford: Oxford University Press. 295 p.
28. Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW, (2008) Nonsteroidal anti-inflammatory drugs for low back pain: an updated cochrane review. Spine 33: 1766-1774.
29. Ward KE, Archambault R, Mersfelder TL, (2010) Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 67: 206-213.
30. Makris UE, Kohler MJ, Fraenkel L, (2010) Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. The Journal of rheumatology 37: 1236-1243.
31. Reame NK, (2005) The emerging science of hot flash relief: legitimizing the 'obecalp' effect. Menopause 12: 4-7.
32. de Jong V, Raz A (2011) Sub-Therapeutic Doses in the Treatment of Depression: The Implications of Starting Low and Going Slow. The Journal of Mind-Body Regulation 1.
33. Kaptchuk TJ, (2002) The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med 136: 817-825.
34. Ernst E, (2000) The role of complementary and alternative medicine. BMJ 321: 1133-1135.
35. Smith R, (1991) Where is the wisdom..? BMJ 303: 798-799.
36. Ellis J, Mulligan I, Rowe J, Sackett DL, (1995) Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet 346: 407-410.
37. Gill P, Dowell AC, Neal RD, Smith N, Heywood P, et al. (1996) Evidence based general practice: a retrospective study of interventions in one training practice. BMJ 312: 819-821.
38. Imrie R, Ramey DW, (2000) The evidence for evidence-based medicine. Complement Ther Med 8: 123-126.
39. Confirmit website. Available: http://www.confirmit.com. Accessed 2013 Feb 7.
40. Heneghan C, Perera R, Mant D, Glasziou P, (2007) Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence. The British journal of general practice: the journal of the Royal College of General Practitioners 57: 948-952.
41. Murray E, (2007) Using the internet for research: results at a keystroke. The British journal of general practice: the journal of the Royal College of General Practitioners 57: 939-940.
42. GMC (2012) List of Registered Medical Practitioners- statistics. London: GMC.
43. Golomb B, (2002) When Are Medication Side Effects Due to the Nocebo Phenomenon? JAMA.
44. Strandvik GF, (2009) Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia 64: 990-1003.
45. Coughlin SS, (1990) Recall bias in epidemiologic studies. Journal of clinical epidemiology 43: 87-91.
46. Mayr A, Gefeller O, Prokosch HU, Pirkl A, Frohlich A, et al. (2012) Web-based data collection yielded an additional response bias-but had no direct effect on outcome scales. Journal of clinical epidemiology 65: 970-977.
47. Worsley A, Baghurst KI, Leitch DR, (1984) Social desirability response bias and dietary inventory responses. Human nutrition Applied nutrition 38: 29-35.
48. Health and Social Care Information Centre Prescribing and Primary Care (2012) Prescription Cost Analysis England 2011. Leeds: Health and Social Care Information Centre Prescribing and Primary Care.
49. Department of Health (2011) 2010-11 reference costs publication. London: NHS.
50. Enck P, Benedetti F, Schedlowski M, (2008) New insights into the placebo and nocebo responses. Neuron 59: 195-206.
51. Colloca L, Finniss D, (2012) Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA: the journal of the American Medical Association 307: 567-568.
52. Cunha BA, (2001) Antibiotic side effects. The Medical clinics of North America 85: 149-185.
53. Howick J (2011) The Philosophy of Evidence-Based Medicine. Oxford: Wiley-Blackwell.
54. Hrobjartsson A, Gotzsche PC (2010) Placebo interventions for all clinical conditions. Cochrane database of systematic reviews: CD003974.